Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
FOXC2 and WT1 regulate transcriptional reprogramming during the podocyte response to injury
Sandrine Ettou, Anya Greenberg, Sangyoon Lee, Arjun Rajesh, Liang Sun, Nahid Tabibzadeh, Haruka Oishi, Ran Konoe, Phillip J. McCown, Sean Eddy, Victoria Driscoll, Tomoya Miyoshi, Ken Hiratsuka, Jason Lam, R. Sathish Srinivasan, Youngsook L. Jung, Biju Isaac, Mingwei Sun, Mary E. Taglienti, Keith Keller, Hong Chen, Matthias Kretzler, Astrid Weins, Ryuji Morizane, Shira Rockowitz, Valerie A. Schumacher, Dongwon Lee, Jordan A. Kreidberg
Sandrine Ettou, Anya Greenberg, Sangyoon Lee, Arjun Rajesh, Liang Sun, Nahid Tabibzadeh, Haruka Oishi, Ran Konoe, Phillip J. McCown, Sean Eddy, Victoria Driscoll, Tomoya Miyoshi, Ken Hiratsuka, Jason Lam, R. Sathish Srinivasan, Youngsook L. Jung, Biju Isaac, Mingwei Sun, Mary E. Taglienti, Keith Keller, Hong Chen, Matthias Kretzler, Astrid Weins, Ryuji Morizane, Shira Rockowitz, Valerie A. Schumacher, Dongwon Lee, Jordan A. Kreidberg
View: Text | PDF
Research Article Genetics Nephrology

FOXC2 and WT1 regulate transcriptional reprogramming during the podocyte response to injury

  • Text
  • PDF
Abstract

Transcriptional reprogramming has an important role in kidney glomerular disease. Using in vivo murine models of podocyte injury, we studied the roles of the FOXC2 and WT1 transcription factors (TFs) in podocyte injury. Podocytes are a crucial cell type of glomeruli, the filtration units of each nephron. Podocyte injury is often the incipient event leading to chronic kidney disease. It is well established that the TFs FOXC2 and WT1 are required in podocytes to maintain the glomerular filtration barrier. Their role in the response to injury is less well understood. Here, we tested the hypothesis that FOXC2 and WT1 act together to mediate transcriptional reprogramming in response to podocyte injury. Similarly to that of WT1, genome-wide FOXC2 binding to target genes is dynamic during the course of injury, initially increasing, but late in injury there is a dramatic decrease in FOXC2 expression and in its binding to target genes. Podocyte-specific inactivation of FoxC2 or Wt1 in adult mice limits the transcriptional response to injury. Correlating FOXC2 and WT1 ChIP-seq analyses demonstrated that they co-bind many genes expressed in podocytes. Thus, reprogramming the transcriptome involves dynamic changes in the binding of FOXC2 and WT1 to their target genes during a reparative injury response.

Authors

Sandrine Ettou, Anya Greenberg, Sangyoon Lee, Arjun Rajesh, Liang Sun, Nahid Tabibzadeh, Haruka Oishi, Ran Konoe, Phillip J. McCown, Sean Eddy, Victoria Driscoll, Tomoya Miyoshi, Ken Hiratsuka, Jason Lam, R. Sathish Srinivasan, Youngsook L. Jung, Biju Isaac, Mingwei Sun, Mary E. Taglienti, Keith Keller, Hong Chen, Matthias Kretzler, Astrid Weins, Ryuji Morizane, Shira Rockowitz, Valerie A. Schumacher, Dongwon Lee, Jordan A. Kreidberg

×

Figure 2

FOXC2 is required for the podocyte response to injury.

Options: View larger image (or click on image) Download as PowerPoint
FOXC2 is required for the podocyte response to injury.
An inducible FoxC...
An inducible FoxC2 shRNA was expressed in podocytes of adult mice. (A) Breeding scheme to obtain shFoxC2/rtTA+ mice used in C–F. Nphs1-rtTA mice are referred to in figures as rtTA. (B) Example of genotyping PCR. (C) Immunofluorescent staining of FOXC2, WT1, and merge, demonstrating loss of FOXC2 and retention of WT1 in shFoxC2/rtTA+ mice. Arrowheads, FOXC2-positive nuclei. Scale bar: 25 μm. (D) Experimental timeline for E and F. (E) mRNA detected by RT-qPCR of FoxC2, Synpo, and Nphs2. The time points after beginning of doxycycline diet (3,000 ppm) and receiving of ADR or PBS control treatment are shown below the graphs. Blue, FoxC2 shRNA without Nphs1-rtTA mice; red, FoxC2 shRNA with Nphs1-rtTA mice. (F) ChIP-qPCR detection of FOXC2 binding. Sites in Nphs2 and Synpo are indicated in Supplemental Figure 1C. Color designation as in E. (G) Mating scheme to obtain homozygous shFoxC2/shfFoxC2/rtTA+ mice. (H) Experimental timeline for mice treated with 6,000 ppm doxycycline (I–K). (I) Urine albumin/creatinine ratios. (J) Top panel: Nephrin localization. Genotypes at left. Left, PBS treated; right, ADR treated. Scale bar: 25 μm. Bottom panel: Grading of nephrin localization patterns. (K) Periodic acid–Schiff–stained histological analysis. Black arrows, protein casts; yellow arrows, protein absorption granules; blue arrows, glomerular collapse. Scale bar: 20 μm. Evaluation of pathological changes is shown in Supplemental Table 1. Data are presented as mean ± SD. Two-way ANOVA or mixed-effects model (E), or 2-way ANOVA with Tukey’s multiple comparison test (F and I); for better visualization, not all P values are shown.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts